download chevron-down chevron-right chevron-with-circle-down chevron-with-circle-up check circle-with-minus circle-with-plus export help-with-circle inbox link mail old-phone star-outlined star user v-card close close close Back to top
Top

Management of Chronic Conditions

CMS eCQM ID Year Type Measure Name
CMS052v7 2019 EP/EC HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS052v8 2020 EP/EC HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS065v8 2019 EP/EC Hypertension: Improvement in Blood Pressure
CMS122v7 2019 EP/EC Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS122v8 2020 EP/EC Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS123v7 2019 EP/EC Diabetes: Foot Exam
CMS131v7 2019 EP/EC Diabetes: Eye Exam
CMS131v8 2020 EP/EC Diabetes: Eye Exam
CMS132v7 2019 EP/EC Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS132v8 2020 EP/EC Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS133v7 2019 EP/EC Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS133v8 2020 EP/EC Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS134v7 2019 EP/EC Diabetes: Medical Attention for Nephropathy
CMS134v8 2020 EP/EC Diabetes: Medical Attention for Nephropathy
CMS135v7 2019 EP/EC Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS135v8 2020 EP/EC Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS143v7 2019 EP/EC Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS143v8 2020 EP/EC Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144v7 2019 EP/EC Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS144v8 2020 EP/EC Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)